Bermele logo

BERM - Bermele Share Price

0.75p 0.0  0.0%

Last Trade - 13/07/20

Sector
Financials
Size
Micro Cap
Market Cap £1.50m
Enterprise Value £1.01m
Revenue £n/a
Position in Universe th / 1816
Bullish
Bearish
Unlock BERM Revenue
Momentum
Relative Strength (%)
1m +0.85%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -70.0%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Jan 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.000 0.000 0.000 0.000 0.000 0.000
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 January 2020, Bermele PLC revenues was not reported. Net loss increased from £112K to £639K. Higher net loss reflects Administrative expenses increase from £112K to £370K (expense), Other Operating Expense increase from £0K to £176K (expense), Stock-based Compensation in SGA increase from £0K to £92K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

BERM Revenue Unlock BERM Revenue

Net Income

BERM Net Income Unlock BERM Revenue

Normalised EPS

BERM Normalised EPS Unlock BERM Revenue

PE Ratio Range

BERM PE Ratio Range Unlock BERM Revenue

Dividend Yield Range

BERM Dividend Yield Range Unlock BERM Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
BERM EPS Forecasts Unlock BERM Revenue
Profile Summary

Bermele PLC is a United Kingdom-based special purpose acquisition company. The Company is formed for the purpose of acquiring a business or businesses operating in the pharmaceutical and biotechnology sectors. Its focus areas include diabetes, cancer, mental health and personalized medicine.

Directors
Last Annual January 31st, 2020
Last Interim January 31st, 2020
Incorporated September 20, 2017
Public Since May 3, 2019
No. of Shareholders: n/a
No. of Employees: 1
Sector Financials
Industry Holding Companies
Index
Exchange London Stock Exchange (Full)
Shares in Issue 200,000,000
Free Float (0.0%)
Eligible for
ISAs
SIPPs
BERM Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for BERM
Upcoming Events for BERM
Frequently Asked Questions for Bermele
What is the Bermele share price?

As of 13/07/20, shares in Bermele are trading at 0.75p, giving the company a market capitalisation of £1.50m. This share price information is delayed by 15 minutes.

How has the Bermele share price performed this year?

Shares in Bermele are currently trading at 0.75p and the price has moved by -50% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Bermele price has moved by -43.93% over the past year.

What are the analyst and broker recommendations for Bermele?

There are no analysts currently covering Bermele.

When will Bermele next release its financial results?

Bermele is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-01-31
What is the Bermele dividend yield?

Bermele does not currently pay a dividend.

Does Bermele pay a dividend?

Bermele does not currently pay a dividend.

When does Bermele next pay dividends?

Bermele does not currently pay a dividend.

How do I buy Bermele shares?

To buy shares in Bermele you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Bermele?

Shares in Bermele are currently trading at 0.75p, giving the company a market capitalisation of £1.50m.

Where are Bermele shares listed? Where are Bermele shares listed?

Here are the trading details for Bermele:

Country of listing: United Kingdom
Exchange: LSE
Ticker Symbol: BERM
What kind of share is Bermele?

We were not able to load our ranking data for Bermele

Is there a Bermele share price forecast 2020?

We were not able to load any forecast data for Bermele.

How can I tell whether the Bermele share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Bermele. Over the past six months, the relative strength of its shares against the market has been -19.79%. At the current price of 0.75p, shares in Bermele are trading at -34.75% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Bermele PE Ratio?

We were not able to find PE ratio data for Bermele.

Who are the key directors of Bermele?

We were unable to find the directors for Bermele.

Who are the major shareholders of Bermele?

Here are the top five shareholders of Bermele based on the size of their shareholding:

Capital Resources, Inc. Hedge Fund
Percentage owned: 10% (20.0m shares)
Hambro Bruetcher Ltd. Corporation
Percentage owned: 5% (10.00m shares)
Bligh (James) Individual Investor
Percentage owned: 5% (10.00m shares)
Pipal Investment Ltd. Corporation
Percentage owned: 4.17% (8.33m shares)
Strada FZE Corporation
Percentage owned: 4.17% (8.33m shares)
Similar to BERM
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.